Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: A review of published experience

Journal of Clinical Psychiatry

Volumn 57, Issue 2, 1996, Pages 55-66

  DeVane, C Lindsay ^a   Sallee, Floyd R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; BUSPIRONE; CARBAMAZEPINE; CLOMIPRAMINE; CYPROHEPTADINE; DESIPRAMINE; DOPAMINE RECEPTOR; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; HYDROCORTISONE; IMIPRAMINE; LITHIUM; LYSERGIDE; METHAMPHETAMINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; NORADRENALIN; PIMOZIDE; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNINDEXED DRUG; URIC ACID;

ADOLESCENT; ANOREXIA; ARTICLE; AUTISM; BULIMIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DEPRESSION; DERMATITIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENURESIS; FEMALE; GILLES DE LA TOURETTE SYNDROME; HALLUCINATION; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MINIMAL BRAIN DYSFUNCTION; NONHUMAN; OBSESSION; PHOBIA; PRADER WILLI SYNDROME; PRIORITY JOURNAL; TREMOR;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CLINICAL TRIALS; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; HUMANS; MALE; MENTAL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0030040860     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. DeVane CL. Pharmacokinetics of the selective serotonin reuptake inhibitors. J Clin Psychiatry 1992;53(2, suppl):13-20
2. Johnson AM. The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals. In: Feighner JP, Boyer WJ, eds. Selective Serotonin Re-Uptake Inhibitors: The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline. Perspective in Psychiatry, vol 1. New York, NY: John Wiley & Sons; 1991:37-70
3. Boyer WF, Feighner JP. The efficacy of selective re-uptake inhibitors in depression. In: Feighner JP, Boyer WJ, eds. Selective Serotonin Re-Uptake Inhibitors: The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline. Perspectives in Psychiatry, vol 1. New York, NY: John Wiley & Sons; 1991:89-108
4. Simeon J, Dinicola V, Phil M, et al. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:791-795
5. Boulos C, Kutcher S, Gardner D, et al. An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. Journal of Child and Adolescent Psychopharmacology 1992;2: 103-111
6. Apter A, Ratzoni G, King RA, et al. Fluvoxamine open-label treatment of adolescent inpatient with obsessive compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry 1994;33:342-348
7. Jain U, Birmaher B, Garcia M, et al. Fluoxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects. Journal of Child and Adolescent Psychopharmacology 1992;2:259-265
8. Riddle MA, Scahill L, King RA, et al. Double-blind trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1992;31:1062-1069
9. Riddle MA, Hardin MT, King R, et al. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1990; 29:45-48
10. Geller DA, Biederman J, Reed ED, et al. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1995;34:36-44
11. Liebowitz MR, Hollander E, Fairbanks J, et al. Fluoxetine for adolescents with obsessive-compulsive disorder [tetter]. Am J Psychiatry 1990;147: 370-371
12. Simeon JG, Thatte S, Wiggins D. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Psychopharmacol Bull 1990;26:285-290
13. Bussing R, Levin GM. Methamphetamine and fluoxetine treatment of a child with attention-deficit hyperactivity disorder and obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology 1993;3:53-58
14. Alessi N, Bos T. Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder [letter]. Am J Psychiatry 1991; 148:1605-1606
15. Graae F, Gitow A, Piacentini J, et al. Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers [tetter]. Am J Psychiatry 1992;149:149-150
16. Kurlan R, Como PG, Deeley C, et al. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clin Neuropharmacol 1993;16:167-172
17. Como PG, Kurlan R. An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome. Neurology 1991;41: 872-874
18. Buckingham D, Gaffney G. New TS treatment [letter]. J Am Acad Child Adolesc Psychiatry 1993;32:224
19. Hamdan-Allen G. Brief report: trichotillomania in an autistic male. J Autism Dev Disord 1991;21:79-82
20. Naylor MW, Grossman M. Trichotillomania and depression [letter]. J Am Acad Child Adolesc Psychiatry 1991;30:155-156
21. Sheikha SH, Wagner KD, Wagner RJ Jr. Fluoxetine treatment of trichotillomania and depression in a prepubertal child. Cutis 1993;51:50-52
22. Gupta MA, Gupta AK. Fluoxetine is an effective treatment for neurotic excoriations: case report. Cutis 1993;51:386-387
23. Alexander RC. Fluoxetine treatment of trichotillomania [letter]. J Clin Psychiatry 1991;52:88
24. Kaye WH, Weltzin TE, Hsu LKG, et al. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991;52:464-471
25. Lyles B, Sarkis E, Kemph JP. Fluoxetine and anorexia. J Am Acad Child Adolesc Psychiatry 1990;29:984-985
26. Iancu I, Ratzoni G, Weitzman A, et al. More fluoxetine experience. J Am Acad Child Adolesc Psychiatry 1992;31:755-756
27. Trygstad O. Drugs in the treatment of bulimia nervosa. Acta Psychiatr Scand Suppl 1990;82(suppl 361):34-37
28. Wilcox JA. Fluoxetine and bulimia. J Psychoactive Drugs 1990;22:81-82
29. Cook EH Jr, Rowlett R, Jaselskis C, et al. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 1992;31:739-745
30. Ghaziuddin M, Tsai L, Ghaziuddin N. Fluoxetine in autism with depression. J Am Acad Child Adolesc Psychiatry 1991;30:508-509
31. Todd RD. Fluoxetine in autism [letter]. Am J Psychiatry 1991;148:1089
32. Mehlinger R, Scheftner WA, Poznanski E. Fluoxetine and autism [letter]. J Am Acad Child Adolesc Psychiatry 1990;29:985
33. McDougle CJ, Price LH, Goodman WK. Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report. J Autism Dev Disord 1990;20:537-543
34. Barrickman L, Noyes R, Kuperman S, et al. Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 1991;30: 762-767
35. Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. Journal of Child and Adolescent Psychopharmacology 1993;3:1-10
36. Birmaher B, Waterman GS, Ryan N, et al. Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 1994;33:993-999
37. Black B, Uhde TW. Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry 1992;31:1090-1094
38. Dech B, Budow L. The use of fluoxetine in an adolescent with Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1991;30:298-302
39. Jerome L. Hypomania with fluoxetine. J Am Acad Child Adolesc Psychiatry 1991;30:850-851
40. King BH. Fluoxetine induced self-injurious behavior in an adolescent with mental retardation. Journal of Child and Adolescent Psychopharmacology 1991;1:321-329
41. Bass JN, Beltis J. Therapeutic effect of fluoxetine on naltrexone-resistant self-injurious behavior in an adolescent with mental retardation. Journal of Child and Adolescent Psychopharmacology 1991;1:331-340
42. Mesaros JD. Fluoxetine for primary enuresis. J Am Acad Child Adolesc Psychiatry 1993;32:877-878
43. Asberg M, Traskman L, Thoren P. 5-HLAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 1976;33:1193-1197
44. 3H-LSD) in the blood platelets of depressed patients. Life Sci 1989;44:725-734
45. Zohar J, Mueller EA, Insel TR, et al. Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 1987;44:946-951
46. Leonard H, Swedo S, Rapoport JL, et al. Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison. Psychopharmacol Bull 1988;24:93-95
47. Insel TR, Mueller EA, Alterman I, et al. Obsessive-compulsive disorder and serotonin: is there a connection? Biol Psychiatry 1985;20:1174-1189
48. Wurtman JJ, Wurtman RJ. Drugs that enhance central serotonergic transmission diminish elective carbohydrate consumption by rats. Life Sci 1979;24:895-904
49. Halmi KA, Eckert E, Flak JR. Cyproheptadine, an antidepressant and weight-inducing drug for anorexia nervosa. Psychopharmacol Bull 1982; 19:103-105
50. 3H]imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sci 1986;38:1235-1242
51. Brewerton TD, Brandt HA, Lesern MD, et al. Serotonin in eating disorders. In: Coccaro EF, Murphy DL, eds. Serotonin in Major Psychiatric Disorders. Washington, DC: American Psychiatric Press; 1990:153-184
52. Robinson PH, Checkley SA, Russell GFM. Suppression of eating by fenfluramine in patients with bulimia nervosa. Br J Psychiatry 1984;146: 169-174
53. Anderson GM, Freedman DX, Cohen DJ, et al. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987;28:885-900
54. McBride PA, Anderson GM, Hertzig ME, et al. Serotonergic responsivity in male young adults with autistic disorder. Arch Gen Psychiatry 1989; 46:213-221
55. Wender PH, Epstein RS, Kopin IF, et al. Urinary monoamine metabolites in children with minimal brain dysfunction. Am J Psychiatry 1971;127: 1411-1415
56. Hanna GL, Yuwiler A, Coates JK. Whole blood serotonin and disruptive behaviors in juvenile obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1995;34:28-35
57. Selikowitz M, Sunman J, Pendergast A, et al. Fenfluramine in Prader-Willi syndrome: a double-blind, placebo controlled trial. Arch Dis Child 1990; 65:112-114
58. Nyhan WL, Johnson HG, Kaufman IA, et al. Serotonergic approaches to the modification of behavior in the Lesch-Nyhan syndrome. Applied Research in Mental Retardation 1980;1:25-40
59. Zohar J, Insel TR. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry 1987;22:667-687
60. Rasmussen SA. Lithium and tryptophan augmentation in clomipramine resistant obsessive-compulsive disoider. Am J Psychiatry 1984;141:1283-1285
61. Golden RN, Morris JE, Sack DA. Combined lithium-tricyclic treatment of obsessive-compulsive disorder. Biol Psychiatry 1988;23:181-185
62. Goodman WK, Price LH, Delgado PL, et al. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1990;47:577-585
63. Jenike MA, Hyman S, Baer L, et al. A controlled trial of fluvoxamine in obsessive-compulsive disorder implications for a serotonergic theory. Am J Psychiatry 1990;147:1209-1215
64. Riddle MA, Brown N, Dzubinski D, et al. Huoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 1989;28:587-588
65. Riddle MA, King RA, Hardin MT, et al. Behavioral side effects of fluoxetine in children and adolescents. Journal of Child and Adolescent Psychopharmacology 1990;1:193-198
66. Koizumi H. Fluoxetine and suicidal ideation [letter]. J Am Acad Child Adolesc Psychiatry 1991;30:695
67. Matthews P, Quinn D, Marcoux GS, et al. Fluoxetine and neuroleptic synergistic effects. J Am Acad Child Adolesc Psychiatry 1991;30:154-155
68. DeMaso DR, Hunter TA. Combining fluoxetine with desipramine [letter]. J Am Acad Child Adolesc Psychiatry 1990;29:151
69. Koo JYM, Smith LL. Obsessive-compulsive disorders in the pediatric dermatology practice. Pediatr Dermatol 1991;8:107-113
70. Antelman SM, Rowland N, Kocan D. Anorectics: lack of cross tolerance among serotonergic drugs and sensitization of amphetamine's effect. In: Garattini S, Samanin R, eds. Anorectic Agents: Mechanisms of Action and Tolerance. New York, NY: Raven Press; 1981:45-61
71. Riederer P, Toifl K, Kruzik P. Excretion of biogenic amine metabolites in anorexia nervosa. Clin Chim Acta 1982;123:27-32
72. Kaye WH, Ebert MH, Raleigh M, et al. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984;41:350-355
73. Gillberg C. Low dopamine and serotonin levels in anorexia nervosa. Am J Psychiatry 1983;140:948-949
74. Lydiard RB, Brady KT, O'Neill PM, et al. Precursor amino acid concentrations in normal weight bulimics and normal controls. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:893-898
75. Hunt RD, Mandl L, Lau S, et al. Neurobiological theories of ADHD and Ritalin. In: Greenhill LL, Osman BB, eds. Ritalin: Theory and Patient Management. New York, NY: May Ann Liebert; 1991:267-287
76. Milich R, Loney J, Landau S. Independent dimensions of hyperactivity and aggression: a validation with playroom observation data. J Abnorm Psychol 1982;91:183-198
77. Biederman J, Baldessarini RJ, Wright V, et al. A double-blind placebo controlled study of desipramine in the treatment of ADD, I: efficacy. J Am Acad Child Adolesc Psychiatry 1989;28:777-784
78. Butler MG, Palmer CG. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet 1983;1:1283-1286
79. Warnock JK, Kestenbaum T. Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Arch Dermatol 1992;128: 1623-1625
80. Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. Am J Med 1964;36:561-570
81. Lipinski JF Jr, Mallya G, Zimmerman P, et al. Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry 1989;50:339-342
82. King RA, Riddle MA, Chappell PB, et al. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 1991;30:179-186
83. Achamallah NS, Decker DH. Mania induced by fluoxetine in an adolescent patient [letter]. Am J Psychiatry 1991;148:1404
84. Jafri AB, Greenberg WM. Fluoxetine side effects [letter]. J Am Acad Child Adolesc Psychiatry 1991;30:852
85. Venkataraman S, Naylor MW, King CA. Mania associated with fluoxetine treatment in adolescents. J Am Acad Child Adolesc Psychiatry 1992;31:276-281
86. Rosenberg DR, Johnson K, Sahl R. Evolving mania in an adolescent treated with low-dose fluoxetine. Journal of Child and Adolescent Psychopharmacology 1992;2:299-306
87. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;147: 207-210
88. Hersh CB, Sokol MS, Pfeffer CR. Transient psychosis with fluoxetine [letter]. J Am Acad Child Adolesc Psychiatry 1991;30:851
89. Walters AM. Sympathomimetic-fluoxetine interaction. J Am Acad Child Adolesc Psychiatry 1992;31:565-566
90. Picker W, Lerman A, Hajal F. Potential interaction of LSD and fluoxetine [letter]. Am J Psychiatry 1992;149:843-844
91. Bradley SJ. Fluoxetine and memory impairment. J Am Acad Child Adolesc Psychiatry 1993;32:1078-1079
92. Bangs ME, Petti TA, Janus M-D. Fluoxetine-induced memory impairment in an adolescent. J Am Acad Child Adolesc Psychiatry 1994;33: 1303-1306
93. Mirow S. Cognitive dysfunction associated with fluoxetine. Am J Psychiatry 1991;148:948-949
94. Urban RJ, Veldhuis JD. A selective serotonin neuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women. Am J Obstet Gynecol 1992;164:147-152
95. Puig-Antich J, Perel JM, Aupatkin W, et al. Imipramine in prepubertal depressive disorder. Arch Gen Psychiatry 1987;44:81-89
96. Ryan ND. Heterocyclic antidepressants in children and adolescents. Journal of Child and Adolescent Psychopharmacology 1990;1:21-31
97. Pigott TA, Pato MT, Bernstein SE, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1990;47:926-932
98. Swedo SE, Leonard HL, Rapoport JL, et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989;321:497-501
99. Gordon CT, State RC, Nelson JE, et al. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 1993;50:441-447
100. DeVane CL. Pharmacogenetics and drug metabolism of newer antidepressant agents. J Clin Psychiatry 1994;55(12, suppl):38-45
101. March JS, Moon RL, Johnston H. Fluoxetine-TCA interaction. J Am Acad Child Adolesc Psychiatry 1990;29:985-986
102. Aranow AB, Hudson JI, Pope HG Jr, et al. Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry 1989;146:911-913
103. Horrigan JP, Barnhill LJ. Paroxetine-pimozide drug interaction. J Am Acad Child Adolesc Psychiatry 1994;33:1061-1062